NEUROPHET
neurophet.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
NEUROPHET is a Seoul medical technology company founded in 2016 that analyses brain imaging with deep learning. Its software segments brain structures to support diagnosis of dementia and plans electrical stimulation treatment. The company sells to hospitals and research institutions in Korea, Japan and Europe.
News
Neurophet Showcases
media1101492Introduces key products including an integrated brain imaging analysis solution for Alzheimer
Read more
Report
Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor
Read more
Report
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer
media733589Neurophet
Read more
Report
Neurophet aims for profitability by analyzing dementia drug side effects through imaging
Neurophet aims for profitability by analyzing dementia drug side effects through imaging Neurophet seeks to enhance healthcare by tapping into the com
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.